283 related articles for article (PubMed ID: 16145785)
1. Model federal policy on protection of human subjects is now final.
Maloney DM
Hum Res Rep; 1991 Aug; 6(8):1-3. PubMed ID: 16145785
[No Abstract] [Full Text] [Related]
2. Widespread IRB-related compliance problems at research institution.
Maloney DM
Hum Res Rep; 2001 Jan; 16(1):6-7. PubMed ID: 11855427
[No Abstract] [Full Text] [Related]
3. Universal protection for all human research participants.
Maloney DM
Hum Res Rep; 2001 Jul; 16(7):1-2. PubMed ID: 11933953
[No Abstract] [Full Text] [Related]
4. Institutional review boards (IRBs) failed to use steps to protect vulnerable research subjects.
Maloney DM
Hum Res Rep; 2003 Jun; 18(6):6-7. PubMed ID: 15119342
[No Abstract] [Full Text] [Related]
5. Are new laws needed to protect human subjects?
Zucker C
Account Res; 2001; 8(3):235-44. PubMed ID: 12481767
[No Abstract] [Full Text] [Related]
6. Federal policy for the protection of human subjects. Final rule.
Fed Regist; 1991 Jun; 56(117):28003-18. PubMed ID: 10112214
[TBL] [Abstract][Full Text] [Related]
7. University's Multiple Project Assurance (MPA) could be renewed for only short periods of time.
Maloney DM
Hum Res Rep; 2000 Jul; 15(7):5-6. PubMed ID: 12199226
[No Abstract] [Full Text] [Related]
8. Protecting human research subjects: ten common problems.
Puglisi T
Health Law News; 2000 Jun; 13(3):8, 15. PubMed ID: 12542046
[No Abstract] [Full Text] [Related]
9. New federalwide assurance for protection of human subjects.
Maloney DM
Hum Res Rep; 2001 Jan; 16(1):1-2. PubMed ID: 11855423
[No Abstract] [Full Text] [Related]
10. Research administrator should not serve on institutional review board.
Maloney DM
Hum Res Rep; 2002 Apr; 17(4):6-7. PubMed ID: 12374181
[No Abstract] [Full Text] [Related]
11. How to interpret the federal policy for the protection of human subjects or "Common Rule" (Part A). [for the Working Group of the Human Subjects Research Subcommittee of the National Science and Technology Council].
Shelton JD
IRB; 1999; 21(6):6-9. PubMed ID: 11697393
[No Abstract] [Full Text] [Related]
12. An evaluation of human subjects protection at CDC/ATSDR.
Santelli J; Ginn E; Speers MA
IRB; 2000; 22(4):1-7. PubMed ID: 11883474
[No Abstract] [Full Text] [Related]
13. Guiding IRBs and educating researchers.
Wood J
Am J Bioeth; 2003; 3(4):W4. PubMed ID: 14744303
[No Abstract] [Full Text] [Related]
14. Research involving children: regulations, review boards and reform.
Gandhi R
J Health Care Law Policy; 2005; 8(2):264-330. PubMed ID: 16471026
[No Abstract] [Full Text] [Related]
15. Bioethical malpractice: risk and responsibilities in human research.
Noah BA
J Health Care Law Policy; 2004; 7(2):175-241. PubMed ID: 15573441
[No Abstract] [Full Text] [Related]
16. Remodelling IRBs.
Silberner J
Hastings Cent Rep; 1998; 28(4):5. PubMed ID: 9762532
[No Abstract] [Full Text] [Related]
17. One unified policy recommended for all human research studies.
Maloney DM
Hum Res Rep; 2001 Oct; 16(10):1-2. PubMed ID: 11833569
[No Abstract] [Full Text] [Related]
18. Medical research oversight from the corporate governance perspective: comparing institutional review boards and corporate boards.
Saver RS
William Mary Law Rev; 2004 Nov; 46(2):619-730. PubMed ID: 17167924
[No Abstract] [Full Text] [Related]
19. Searching for "research involving human subjects"--What is examined? What is exempt? What is exasperating?
Pritchard IA
IRB; 2001; 23(3):5-13. PubMed ID: 11789525
[No Abstract] [Full Text] [Related]
20. Regulating human gene therapy: legislative overreaction to human subject protection failures.
Leavitt WJ
Adm Law Rev; 2001; 53(1):315-41. PubMed ID: 16189905
[No Abstract] [Full Text] [Related]
[Next] [New Search]
